ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IVF vs ICCM // FORWARD P/E MULTIPLE

INVO Fertility Inc. (NASDAQ) VS. IceCure Medical Ltd. (NASDAQ) • 15-METRIC TALLY: IVF 3 — ICCM 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IVF VS. ICCM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IVF ICCM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 36.30% +59.70 IVF /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin 68.00% -60.00% +128.00 IVF /net-margins <GO>
Revenue Growth (YoY) 4.30% 2.70% +1.60 IVF /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 14.3 28.5 -14.20 ICCM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.5M $3.3M -$811.2K ICCM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IVF REV ICCM REV IVF GROSS % ICCM GROSS % IVF FCF ICCM FCF
FY 2025 $6.8M $3.4M 98.0% 36.3% -$7.1M -$14.6M
FY 2024 $6.6M $3.3M 43.3% 44.1% -$3.2M -$12.6M
FY 2023 $3.0M $3.2M — — -$4.8M -$12.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IVF // BETA —
ICCM // BETA —